S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Unisys Proposes New Framework to Build Trust in Medical AI

A new research paper published in Frontiers in Pharmacology addresses the critical gap between machine learning accuracy and clinical reliability, proposing a neurosymbolic approach to drug repurposing. The study, led by Unisys, seeks to replace opaque algorithmic decision-making with transparent, mechanistically explainable systems for highly regulated healthcare environments.

Unisys Proposes New Framework to Build Trust in Medical AI
Photo: Bio & News

The research introduces the MURP framework—an acronym for Mechanistic Coherence, Uncertainty, Robustness and Provenance—designed to evaluate AI beyond simple predictive performance. By integrating human reasoning with advanced machine learning, the neurosymbolic model aims to provide the clear visibility required for medical professionals to validate AI-generated recommendations.

Salvatore Sinno, vice president of innovation at Unisys, emphasized that the shift toward credible AI is essential for enterprise adoption. As organizations look to deploy automated systems in complex, high-stakes settings, the ability to govern and justify outcomes becomes as vital as the technical output itself. This work aligns with the company’s broader AI-First strategy, which prioritizes moving beyond experimental models toward scalable, auditable business applications.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!